Creative Capital Management Investments LLC
Position in EXEL — Exelixis, Inc.
CIK 1957363
SAN DIEGO, CA
Position in EXEL
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,536
New position
Shares Held
65
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#703
of 754 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creative Capital Management Investments LLC holds $60,167 across 29 Biotechnology names. EXEL ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
40 | $19,869 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7 | $4,364 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
116 | $4,105 | |
| 4 | INCY |
Incyte Corp
|
36 | $4,080 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
65 | $3,536 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
12 | $2,891 | |
| 7 | MRNA |
Moderna, Inc.
|
41 | $2,871 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
50 | $2,861 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,536 | 65 | Shares | Sole | 2026-07-24 | |
| No filing history on record for this holder in this stock. | ||||||